142 related articles for article (PubMed ID: 3956136)
21. Effects of clindamycin in combination with rifampicin on clindamycin-susceptible and clindamycin-resistant Staphylococcus aureus.
Watanakunakorn C
J Antimicrob Chemother; 1985 Sep; 16(3):335-9. PubMed ID: 4055542
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of coumermycin alone or in combination against Staphylococcus aureus and Staphylococcus epidermidis.
Van der Auwera P; Klastersky J
Drugs Exp Clin Res; 1986; 12(4):307-11. PubMed ID: 3013562
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of vancomycin-beta-lactam combinations against heterogeneously vancomycin-resistant Staphylococcus aureus (hetero-VRSA).
Kim YS; Kiem S; Yun HJ; Jung SI; Oh WS; Kim SW; Peck KR; Lee NY; Song JH
J Korean Med Sci; 2003 Jun; 18(3):319-24. PubMed ID: 12808315
[TBL] [Abstract][Full Text] [Related]
24. Interaction between vancomycin and rifampin against Staphylococcus aureus.
Watanakunakorn C; Guerriero JC
Antimicrob Agents Chemother; 1981 Jun; 19(6):1089-91. PubMed ID: 7271276
[TBL] [Abstract][Full Text] [Related]
25. Serum bactericidal activity of rifampin in combination with other antimicrobial agents against Staphylococcus aureus.
Hackbarth CJ; Chambers HF; Sande MA
Antimicrob Agents Chemother; 1986 Apr; 29(4):611-3. PubMed ID: 3707110
[TBL] [Abstract][Full Text] [Related]
26. MIC versus MBEC to determine the antibiotic sensitivity of Staphylococcus aureus in peritoneal dialysis peritonitis.
Girard LP; Ceri H; Gibb AP; Olson M; Sepandj F
Perit Dial Int; 2010; 30(6):652-6. PubMed ID: 21148059
[TBL] [Abstract][Full Text] [Related]
27. Novobiocin and rifampicin in combination against methicillin-resistant Staphylococcus aureus: an in-vitro comparison with vancomycin plus rifampicin.
Walsh TJ; Auger F; Tatem BA; Hansen SL; Standiford HC
J Antimicrob Chemother; 1986 Jan; 17(1):75-82. PubMed ID: 3633267
[TBL] [Abstract][Full Text] [Related]
28. Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Lowy FD; Chang DS; Lash PR
Antimicrob Agents Chemother; 1983 Jun; 23(6):932-4. PubMed ID: 6555016
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea.
Baek YS; Jeon J; Ahn JW; Song HJ
Int J Dermatol; 2016 Apr; 55(4):e191-7. PubMed ID: 26892888
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
[TBL] [Abstract][Full Text] [Related]
31. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
Rand KH; Houck HJ
Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
[TBL] [Abstract][Full Text] [Related]
32. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
Drugeon HB; Caillon J; Juvin ME
J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
[TBL] [Abstract][Full Text] [Related]
33. Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.
Tsuji BT; Rybak MJ
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):73-7. PubMed ID: 16368477
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods.
Jacqueline C; Caillon J; Le Mabecque V; Miegeville AF; Donnio PY; Bugnon D; Potel G
J Antimicrob Chemother; 2003 Apr; 51(4):857-64. PubMed ID: 12654769
[TBL] [Abstract][Full Text] [Related]
35. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
Lorian V; Atkinson B; Kim Y
Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
[TBL] [Abstract][Full Text] [Related]
36. [Drug-resistance of staphylococcus aureus and detection of mecA gene in all strains isolated from children in Hangzhou].
Hua CZ; Li JP; Yu HM; Li S; Ye H; Shang SQ
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):360-3. PubMed ID: 16780714
[TBL] [Abstract][Full Text] [Related]
37. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
38. In vitro antistaphylococcal activity of pefloxacin alone and in combination with other antistaphylococcal drugs.
Fass RJ; Helsel VL
Antimicrob Agents Chemother; 1987 Oct; 31(10):1457-60. PubMed ID: 3481244
[TBL] [Abstract][Full Text] [Related]
39. Is in vitro antibiotic combination more effective than single-drug therapy against anthrax?
Athamna A; Athamna M; Nura A; Shlyakov E; Bast DJ; Farrell D; Rubinstein E
Antimicrob Agents Chemother; 2005 Apr; 49(4):1323-5. PubMed ID: 15793105
[TBL] [Abstract][Full Text] [Related]
40. Synergistic effects of vancomycin and β-lactams against vancomycin highly resistant Staphylococcus aureus.
Tabuchi F; Matsumoto Y; Ishii M; Tatsuno K; Okazaki M; Sato T; Moriya K; Sekimizu K
J Antibiot (Tokyo); 2017 Jun; 70(6):771-774. PubMed ID: 28196977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
